铁纳米颗粒优化方面的进展:为生物医学应用解锁抗真菌特性
Zeshan Ali Sandhu1, Muhammad Asam Raza1, Abdulmajeed Alqurashi2
1Department of Chemistry, Faculty of Science, Hafiz Hayat Campus, University of Gujrat, Gujrat 50700, Pakistan.
Pharmaceutics
|May 25, 2024
概括
铁纳米粒子 (Fe NPs) 显示出对抗真菌感染的巨大潜力. 本综述涵盖了它们的合成,特性和抗真菌应用,强调了医疗用途的安全和有效输送.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术 纳米技术
- 菌类学 菌类学是指菌类学.
背景情况:
- 纳米技术为生物挑战提供先进的解决方案,特别是在抗真菌治疗中.
- 铁纳米粒子 (Fe NPs) 越来越多地被认为具有对抗真菌病的潜力.
- 开发有效和安全的纳米材料对于推进医疗应用至关重要.
研究的目的:
- 为抗真菌应用提供铁纳米颗粒 (FeNP) 的全面审查.
- 探索Fe NP的合成方法,特性,表征和优化.
- 讨论Fe NP输送系统,生物相容性,毒性和临床过渡的挑战.
主要方法:
- 对Fe NPs的合成方法和工作原理的文献综述.
- 分析影响Fe NP特性和抗真菌潜力的因素.
- 检查Fe NP输送平台及其相关的毒理学概况.
- 对Fe NP在生物医学中的应用进行生物相容性和毒性数据的审查.
主要成果:
- FeNP对抗真菌应用具有显著的潜力.
- 对于Fe NP,有各种合成和表征技术可用.
- 优化Fe NP输送系统可以提高效率并降低毒性.
- 生物相容性和毒性是临床转换的关键因素.
结论:
- NP是一种有前途的纳米材料类别,用于抗真菌疗法.
- 对安全和有效的输送系统的进一步研究对于临床采用至关重要.
- 解决监管和安全问题对于FeNP从实验室到临床的过渡至关重要.
相关概念视频
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Microbial Corrosion
111
Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
111
Antifungal Agents
131
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
131


